Experts disagree about ‘probably carcinogenic’ processed meat.

The World Health Organisation (WHO) has taken the step of classifying processed meat as carcinogenic, which now means that ham, bacon and salami are classified in the same category as alcohol, tobacco, asbestos and arsenic.

Large-scale study

There is "sufficient evidence" to draw a link between the consumption of processed-meat products and cancer, said the WHO's experts, who belong to the International Agency for Research on Cancer (IARC), after studying more than 800 cases.

Pfizer y Allergan negocian crear la mayor compañía de salud.

Pfizer vuelve a intentarlo tras el intento fallido de hacerse con el control de la británica AstraZeneca. La farmacéutica estadounidense trata ahora de fusionarse con la irlandesa Allergan. Las dos compañías, con un valor combinado de 330.000 millones de dólares, confirmaron que discuten la posibilidad. Aunque está todo en una fase muy preliminar, la sola intención sumar fuerzas volvió a avivar el debate sobre maniobras corporativas que buscan reducir la carga fiscal.

Enlitic CEO: Deep-Learning Software Could Soon Help Diagnose Patients.

“Take two aspirin and call me in the morning” is the punch line to decades’ worth of doctor-diagnosis jokes, but San Francisco software company Enlitic doesn’t see the humor in it. Enlitic is building a computer system to help doctors make faster, more accurate diagnoses, and it’s gotten its first major customer in the Australian radiology provider Capitol Health.

An Online Medical Database Is Reducing Diagnostic Errors.

Diagnostic errors burden providers, payers, and patients around the world. They lead to avoidable illness, suffering, and poor health outcomes and increase costs of care significantly. Access to evidence-based medical content at the point of care that answers clinical questions and ensures accuracy in diagnosis can reduce diagnostic errors and improve outcomes. Our organizations are involved in the efforts to expand global access. We encourage others to join us in this effort and offer three recommendations for accelerating this drive.

Deep learning startup Enlitic raises $10M from radiology company Capitol Health.

Enlitic, a startup using a type of artificial intelligence called deep learning to help radiologists do a better job of understanding medical images, is announcing today a $10 million round of funding. The money comes from Capitol Health Limited, a publicly traded company that provides diagnostic imaging services in clinics across Australia.

El 17% de la ropa de los hospitales madrileños regresa sucia de la lavandería.

Uniformes de médicos y de personal de enfermería con manchas y desgarrones. Sábanas y toallas que llegan húmedas o con descosidos. El hospital de La Paz lleva meses recibiendo ropa de la lavandería privatizada de Mejorada que no puede usar, como han denunciado sus trabajadores. No es un problema puntual. Más de un tercio de la ropa de los 19 hospitales públicos madrileños se considera “no utilizable”: llega sucia (17%), arrugada (12%) o no vuelve parte de la que se envió a lavar.

EEUU autoriza la comercialización de Yondelis, el antitumoral de Zeltia.

Tras rechazarlo en 2009, las autoridades estadounidenses por fin han dado el visto bueno al medicamento Yondelis, el antitumoral de Zeltia que comenzará a comercializarse en EEUU.

PharmaMar ha anunciado hoy que su socio Janssen Biotech ha recibido la aprobación de comercialización de Yondelis por la Agencia de Alimentos y Medicamentos de EEUU (FDA) para el tratamiento de pacientes con liposarcoma o con leiomiosarcoma, dos subtipos de sarcoma de tejidos blandos.

Éste es el primer tratamiento aprobado específicamente para pacientes con liposarcoma en EEUU, señala Zeltia a la Comisión Nacional del Mercado de Valores (CNMV).

Israeli scientists tout new method for battling depression.

A paper by Israeli brain researchers suggests a new direction for studying and treating depression.

Prof. Raz Yirmiya, who heads Hebrew University’s psychoneuroimmunology laboratory, is the senior author of a new paper, “Depression as a microglial disease,” published in the October issue of Trends in Neurosciences.

The paper urges a new focus in depression research away from neurons, the cells that make up the brain’s thinking faculties and allow it to control the body, and toward brain cells called microglia.

Páginas

Suscribirse a RSS - salud